1987
DOI: 10.1001/archinte.1987.00370020147053
|View full text |Cite
|
Sign up to set email alerts
|

Treatment of Cancer-Associated Hypercalcemia With Cisplatin

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

1987
1987
1992
1992

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 16 publications
(1 citation statement)
references
References 14 publications
(3 reference statements)
0
1
0
Order By: Relevance
“…Clinical experience with cisplatin used in refractory hypercalcemia for patients with cancer has been reported. Lad et al [12] demonstrated that a single 24 hour infusion of 100 mg/m2 of cisplatin was able to normalize the serum calcium in 9 of 13 patients who had been previously hydrated but remained hypercalcemic. None of the patients reported by these authors had any decrease in tumor size following treatment.…”
Section: Discuss I 0 Nmentioning
confidence: 99%
“…Clinical experience with cisplatin used in refractory hypercalcemia for patients with cancer has been reported. Lad et al [12] demonstrated that a single 24 hour infusion of 100 mg/m2 of cisplatin was able to normalize the serum calcium in 9 of 13 patients who had been previously hydrated but remained hypercalcemic. None of the patients reported by these authors had any decrease in tumor size following treatment.…”
Section: Discuss I 0 Nmentioning
confidence: 99%